美股A股
StockGist
Back
8-K2026-03-11· grok-4-1-fast-non-reasoning

QUCY · Mainz Biomed N.V.

0001213900-26-025940

SEC filing

Summary

Mainz Biomed B.V. filed an 8-K on March 11, 2026, disclosing matters under Items 5.02, 7.01, and 8.01, including a departure or election of directors or officers, a furnished press release (Exhibit 99.1), and that ordinary shares will cease trading effective before market open on March 12, 2026.

Key takeaways